250 employees
Immunologix develops and produces antibody-based therapeutics against viral, bacterial, and tumor antigens, as well as human auto antigens.
2008
$200K
from 1 investors over 1 rounds
Immunologix, Inc. raised $200K on March 12, 2010
Investors: SCRA